Improving Productivity by Optimizing Manufacturing Processes

Related Vendors

Turck_Your_Global_Automation_Partner.jpg ()

High-potency active pharmaceutical ingredients (HPAPIs), for example, is a fast growing segment, and is projected to grow at a compound annual growth rate (CAGR) of 9.9 per cent through 2018. To keep pace with these advances, engineering expertise is required to design equipment that can handle, package and secure such substances,” asserts Harbauer.

According to him, pharmaceuticals, biopharmaceuticals, vaccines and anti-virals must be manufactured and packaged with the utmost caution and attention-to-detail. It is with these requirements in mind that he sees the following trends: a rising demand for pharmaceutical quality and safety through inspection technology; the ability to handle potent substances; adapting lines for small batch sizes and research purposes; an increasing use of single-use components; and, the need to improve productivity by optimizing manufacturing processes with respect to Overall Equipment Effectiveness (OEE).

Automation has to Keep Pace with the Advances in Pharmaceutical Developments

Price is another issue which is a very important factor and according to Dr. Pasbrig is often ranked higher than quality. According to him the need of the hour is to save costs without influencing the quality and performance of the packaging material.

“Another point is service and delivery time. India is a market with very short notice of orders. Better planning would help both sides to increase efficiency in production.” The first quarter of 2013 has seen a sudden spike in the number of opportunities in the Indian pharma market. “Almost all the opportunities are on turnkey basis including automation, instrumentation & field activities. Today, we observe that the role of a consultant in this sector has increased. Consultants play a vital role in the decision making for suitable automation partner on behalf of the customer. Hence, it’s key that the automation vendors adopt a strategic approach to convince these consultants. The inrush of global pharma companies for manufacturing in India is increasing, thus opening the gates for huge opportunities,” says Maennl.

(ID:42264680)